ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

The Health Benefits of Manuka Honey

Increase Your Magnesium Intake

Vitamin D supplementation could ease IBS symptoms

Top Tips to Boost Your Immunity

11 Amazing Health Benefits of Using Baking Soda

Nicotinamide riboside shows promise for treatment of Alzheimer’s disease

Exercise, calcium, vitamin D, and other factors linked with fewer injurious falls

Vitamin D3 Is a Powerhouse for Your Heart

Rhodiola — A Powerful Adaptogen That Boosts Vitality and Performance, Eases Depression and Combats B...

Curcumin Supplementation May Impart Long-Term Cognitive Benefits

 
Print Page
Email Article

Behavioral Therapies No Cure for Chronic Fatigue Syndrome (CFS)

  [ 51 votes ]   [ Discuss This Article ]
www.ProHealth.com • December 12, 2001


JAMA study may be misleading

This article is reprinted with permission from The CFS Research Review Vol. 2, No. 4 Fall 2001.

A review article in the Sept. 19, 2001 issue of the Journal of the American Medical Association states what most familiar with the chronic fatigue syndrome (CFS) literature already know: studies of treatments in CFS involve small numbers of participants, use inconsistent outcome measures and yield mixed results.

The authors have summarized the results of two government-funded analyses (one from the U.S. and the other from the U.K.) of the treatment literature, including published and unpublished reports of pharmacologic, behavioral and other therapies. Nineteen databases were searched, identifying 350 studies conducted between 1986 and 2000. Of those, 44 research reports were included in the review, representing a total of 2,801 patients.

Reviewers selected studies of pharmacologic interventions including hydrocortisone, fludrocortisone and galanthamine and immunological therapies such as immunoglobulin, Ampligen and interferon. Trials of supplements such as essential fatty acids and magnesium were evaluated, as were studies of massage and osteopathy. Research on two behavioral interventions, graded exercise therapy (GET) and cognitive behavioral therapy (CBT), accounted for nine of the 44 studies.

Comparison of the studies proved challenging. There were considerable differences in study design (36 employed randomized controlled trials and eight used controlled trials), outcome measures (more than 38 different outcomes were assessed), duration of treatment (ranging from two to 52 weeks) and length of follow-up (ranging from two weeks to five years).

The authors highlighted CBT and GET as the most promising therapies, although they acknowledge that these studies also had the highest dropout rates of the 44. Five of the nine behavioral studies used the less-restrictive Oxford criteria to select patients, and all, by design, only included patients who were well enough to frequently travel to clinic.

Positive effects of other therapies received less attention. Of those studies with relatively high validity scores, independent trials of immunoglobulin, hydrocortisone, magnesium and essential fatty acids showed benefits.

The reviewers conclude that greater standardization of studies is needed. They suggest that a classification system for illness severity be developed, as well as guidelines for the duration of intervention and follow-up. Finally, the authors prioritize agreement upon outcome measures as a necessary step to improve the comparability of CFS studies.

The complete report of the U.S. evidence based review summarized in the JAMA article is due from the Agency for Healthcare Research and Quality in late November or early December. The U.K. literature analysis is available on the Internet at www.york.ac.uk/inst/crd/cfs.htm.



Post a Comment

Featured Products From the ProHealth Store
Optimized Curcumin Longvida® Mitochondria Ignite™ with NT Factor® FibroSleep™


Article Comments



Be the first to comment on this article!

Post a Comment


 
Optimized Curcumin Longvida with Omega-3

Featured Products

Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get Energized with Malic Acid & Magnesium
Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%
Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils
Optimized Curcumin Longvida® Optimized Curcumin Longvida®
Supports Cognition, Memory & Overall Health
FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid

Natural Remedies

Milk Thistle: Trusted Support for Health & Healing in a Toxic World Milk Thistle: Trusted Support for Health & Healing in a Toxic World
Green Coffee Extract: Unique Obesity Intervention Green Coffee Extract: Unique Obesity Intervention
Block food Cravings At Their Molecular Root Block food Cravings At Their Molecular Root
Prepare Yourself for Cold & Flu Season Prepare Yourself for Cold & Flu Season
Can Pomegranates Slow Aging? Can Pomegranates Slow Aging?

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE TO OUR NEWSLETTERS
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2018 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map